Literature DB >> 31037295

Patients With Good Vision and Diabetic Macular Edema Involving the Center of the Macula: To Treat or Not to Treat?

Emily Y Chew1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31037295      PMCID： PMC8341102          DOI： 10.1001/jama.2019.5793

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  The Clinical Importance of Changes in Diabetic Retinopathy Severity Score.

Authors:  Michael S Ip; Jiameng Zhang; Jason S Ehrlich
Journal:  Ophthalmology       Date:  2017-03-08       Impact factor: 12.079

2.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

3.  Effects of medical therapies on retinopathy progression in type 2 diabetes.

Authors:  Emily Y Chew; Walter T Ambrosius; Matthew D Davis; Ronald P Danis; Sapna Gangaputra; Craig M Greven; Larry Hubbard; Barbara A Esser; James F Lovato; Letitia H Perdue; David C Goff; William C Cushman; Henry N Ginsberg; Marshall B Elam; Saul Genuth; Hertzel C Gerstein; Ulrich Schubart; Lawrence J Fine
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

4.  Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Authors:  Quan Dong Nguyen; David M Brown; Dennis M Marcus; David S Boyer; Sunil Patel; Leonard Feiner; Andrea Gibson; Judy Sy; Amy Chen Rundle; J Jill Hopkins; Roman G Rubio; Jason S Ehrlich
Journal:  Ophthalmology       Date:  2012-02-11       Impact factor: 12.079

5.  A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

Authors:  Michel Michaelides; Andrew Kaines; Robin D Hamilton; Samantha Fraser-Bell; Ranjan Rajendram; Fahd Quhill; Christopher J Boos; Wen Xing; Catherine Egan; Tunde Peto; Catey Bunce; R David Leslie; Philip G Hykin
Journal:  Ophthalmology       Date:  2010-04-22       Impact factor: 12.079

6.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

7.  Long-term effects of ranibizumab on diabetic retinopathy severity and progression.

Authors:  Michael S Ip; Amitha Domalpally; J Jill Hopkins; Pamela Wong; Jason S Ehrlich
Journal:  Arch Ophthalmol       Date:  2012-09

8.  Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group.

Authors:  F L Ferris
Journal:  JAMA       Date:  1991-09-04       Impact factor: 56.272

9.  Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

Authors:  John A Wells; Adam R Glassman; Allison R Ayala; Lee M Jampol; Neil M Bressler; Susan B Bressler; Alexander J Brucker; Frederick L Ferris; G Robert Hampton; Chirag Jhaveri; Michele Melia; Roy W Beck
Journal:  Ophthalmology       Date:  2016-02-27       Impact factor: 12.079
View more
  2 in total

1.  NATURAL HISTORY AND PREDICTORS OF VISION LOSS IN EYES WITH DIABETIC MACULAR EDEMA AND GOOD INITIAL VISUAL ACUITY.

Authors:  Daniella Lent-Schochet; Therlinder Lo; Kieu-Yen Luu; Steven Tran; Machelle D Wilson; Ala Moshiri; Susanna S Park; Glenn Yiu
Journal:  Retina       Date:  2021-10-01       Impact factor: 3.975

Review 2.  The Evolving Treatment of Diabetic Retinopathy.

Authors:  Sam E Mansour; David J Browning; Keye Wong; Harry W Flynn; Abdhish R Bhavsar
Journal:  Clin Ophthalmol       Date:  2020-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.